Skip to main content

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

Publication ,  Journal Article
Virani, SS; Newby, LK; Arnold, SV; Bittner, V; Brewer, LC; Demeter, SH; Dixon, DL; Fearon, WF; Hess, B; Johnson, HM; Kazi, DS; Kolte, D ...
Published in: Circulation
August 29, 2023

AIM: The "2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease" provides an update to and consolidates new evidence since the "2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease" and the corresponding "2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease." METHODS: A comprehensive literature search was conducted from September 2021 to May 2022. Clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants were identified that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. STRUCTURE: This guideline provides an evidenced-based and patient-centered approach to management of patients with chronic coronary disease, considering social determinants of health and incorporating the principles of shared decision-making and team-based care. Relevant topics include general approaches to treatment decisions, guideline-directed management and therapy to reduce symptoms and future cardiovascular events, decision-making pertaining to revascularization in patients with chronic coronary disease, recommendations for management in special populations, patient follow-up and monitoring, evidence gaps, and areas in need of future research. Where applicable, and based on availability of cost-effectiveness data, cost-value recommendations are also provided for clinicians. Many recommendations from previously published guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.

Duke Scholars

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

August 29, 2023

Volume

148

Issue

9

Start / End Page

e9 / e119

Location

United States

Related Subject Headings

  • United States
  • Proliferating Cell Nuclear Antigen
  • Myocardial Ischemia
  • Humans
  • Coronary Disease
  • Cardiovascular System & Hematology
  • Cardiology
  • American Heart Association
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., … Peer Review Committee Members. (2023). 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation, 148(9), e9–e119. https://doi.org/10.1161/CIR.0000000000001168
Virani, Salim S., L Kristin Newby, Suzanne V. Arnold, Vera Bittner, LaPrincess C. Brewer, Susan Halli Demeter, Dave L. Dixon, et al. “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.Circulation 148, no. 9 (August 29, 2023): e9–119. https://doi.org/10.1161/CIR.0000000000001168.
Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, Dixon DL, Fearon WF, Hess B, Johnson HM, Kazi DS, Kolte D, Kumbhani DJ, LoFaso J, Mahtta D, Mark DB, Minissian M, Navar AM, Patel AR, Piano MR, Rodriguez F, Talbot AW, Taqueti VR, Thomas RJ, van Diepen S, Wiggins B, Williams MS, Peer Review Committee Members. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023 Aug 29;148(9):e9–e119.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

August 29, 2023

Volume

148

Issue

9

Start / End Page

e9 / e119

Location

United States

Related Subject Headings

  • United States
  • Proliferating Cell Nuclear Antigen
  • Myocardial Ischemia
  • Humans
  • Coronary Disease
  • Cardiovascular System & Hematology
  • Cardiology
  • American Heart Association
  • 4207 Sports science and exercise
  • 3202 Clinical sciences